FTC is Targeting Private Equity Acquisitions in Healthcare – Is Your Industry Next?

On March fifth, the Federal Trade Commission convened a workshop with regulators, academics and stakeholders to discuss the impact of private equity in the healthcare market. The workshop reflects both the FTC and DOJ Antitrust Division’s recent focus on private equity and serial roll-up transactions more broadly as targets for antitrust enforcement. Read the full article.About the authorIan DickinsonLee K. Van Voorhis